Release Date: 24/10/18 16:53 Summary: Class - Leadership Change Price Sensitive: Yes Download Document 133.3KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%